Home
ADAR1 Capital Management reported a 5.1% stake in Ovid Therapeutics OVID · 9,559,979 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5.1%
- Last report
- 6.9% · filed 26/02/17
- Shares held
- 9,559,979 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- ADAR1 Capital Management
- Event date
- 26/06/30
- Filed
- 26/08/14
5.1% stake · −1.8pp from the last report
- Stake
- 5.1%
- Last report
- 6.9%
- Since last report
- −1.8pp
Ovid Therapeutics trades, last 26 weeks
What else happened in Ovid Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30ADAR1 Capital Management's other 5% stake reports
- ADAR1 Capital Management
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
14% stake
5,257,389 sh
14% stake
Filed 09/08
- ADAR1 Capital Management
5% stakeNextCure
5% stakeNextCure
NXTC
15.8% stake
722,419 sh
15.8% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
8.8% stake
59,000 sh
8.8% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeRein Therapeutics
5% stakeRein Therapeutics
RNTX
5.3% stake
4,500,000 sh
5.3% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeResearch Alliance Corp III
5% stakeResearch Alliance Corp III
RACC
8.4% stake
650,000 sh
8.4% stake
Filed 08/14
